Xanthine oxidase inhibition and heart failure: novel therapeutic strategy for ventricular dysfunction?

Circ Res. 2006 Feb 3;98(2):169-71. doi: 10.1161/01.RES.0000204557.09610.01.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allopurinol / therapeutic use
  • Animals
  • Cardiomyopathy, Dilated / drug therapy*
  • Enzyme Inhibitors / therapeutic use*
  • Heart Failure / drug therapy*
  • Heart Failure / metabolism
  • Rats
  • Reactive Oxygen Species
  • Ventricular Dysfunction / drug therapy*
  • Xanthine Oxidase / antagonists & inhibitors*
  • Xanthine Oxidase / physiology

Substances

  • Enzyme Inhibitors
  • Reactive Oxygen Species
  • Allopurinol
  • Xanthine Oxidase